Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Two forms of paracetamol among latest March price concessions

The Department of Health and Social Care and the National Assembly for Wales have agreed concessionary prices for the following 14 items for March 2020 prescriptions.

An initial 24 price concessions were announced on March 13, and a further 19 items were added to the list on March 19.

Drug
Strength
Form
Price
Clarithromycin
250mg/5ml
oral suspension (70ml)
£5.77
Erythromycin
250mg
gastro-resistant tablets (28)
£8.85
Fenofibrate micronised
267mg
capsules (28)
£2.80
Ibuprofen
400mg
tablets (24)
£1.25
Ibuprofen
400mg
tablets (84)
£4.38
Isosorbide mononitrate
20mg
tablets (56)
£1.48
Metronidazole
400mg
tablets (21)
£5.15
Naproxen
250mg
tablets (28)
£3.74
Nitrazepam
5mg
tablets (28)
£5.60
Paracetamol
500mg
capsules (32)
£1.23
Paracetamol
500mg
capsules (100)
£3.85
Paracetamol
120mg/5ml oral suspension
paediatric sugar free (100ml)
£1.60
Perindopril erbumine
2mg
tablets (30)
£2.99
Rosuvastatin
5mg
tablets (28)
£1.95

Do these prices reflect what you have paid in March so far?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD006412

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel